Tirzepatide helped steatohepatitis with fibrosis in phase II trials
US, Italian, French and Japanese researchers reported success in a phase II clinical trial of tirzepatide for the treatment of metabolic dysfunction-associated steatohepatitis (MDAS) and liver fibrosis
20.06.2024